Infinity Pharmaceuticals Inc (NASDAQ:INFI)
| 0.1786 Delayed Data As of Jun 02 |  -0.0035 / -1.92%Today’s Change | 0.12 Today|||52-Week Range 1.76 | -67.82% Year-to-Date |
Latest INFI News | Press Releases
No recent news for Infinity Pharmaceuticals Inc.
Today’s Trading
| Previous close | 0.18 |
| Today’s open | 0.19 |
| Day’s range | 0.18 - 0.19 |
| Volume | 8,519 |
| Average volume (3 months) | 940,268 |
| Market cap | $16.2M |
Data as of 3:18pm ET, 06/02/2023
Growth & Valuation
| Earnings growth (last year) | +5.99% |
| Earnings growth (this year) | +8.00% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +39.56% |
| P/E ratio | NM |
| Price/Sales | 19.10 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| APDNApplied DNA Sciences... | -0.02 | -1.57% |
| MRKRMarker Therapeutics ... | +0.14 | +8.33% |
| CLRBCellectar Bioscience... | 0.00 | 0.00% |
| ---- |
Data as of 3:59pm ET, 06/02/2023
Financials
| Next reporting date | August 8, 2023 |
| EPS forecast (this quarter) | -$0.12 |
| Annual revenue (last year) | $2.6M |
| Annual profit (last year) | -$44.4M |
| Net profit margin | -1,711.11% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
